Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Graham Andrew Colditz, M.D., Dr.P.H., M.B.,B.S.

Co-Author

This page shows the publications co-authored by Graham Colditz and Laura Collins.
Connection Strength

1.755
  1. Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies. Cancer. 2016 Feb 15; 122(4):515-20.
    View in: PubMed
    Score: 0.167
  2. Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. Pediatrics. 2012 May; 129(5):e1192-8.
    View in: PubMed
    Score: 0.130
  3. Adolescent intakes of alcohol and folate and risk of proliferative benign breast disease. J Clin Oncol. 2011 Sep 20; 29(27_suppl):169.
    View in: PubMed
    Score: 0.125
  4. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat. 2012 Jan; 131(1):159-67.
    View in: PubMed
    Score: 0.124
  5. The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study. Breast Cancer Res Treat. 2011 Aug; 129(1):175-84.
    View in: PubMed
    Score: 0.121
  6. Intake of fiber and nuts during adolescence and incidence of proliferative benign breast disease. Cancer Causes Control. 2010 Jul; 21(7):1033-46.
    View in: PubMed
    Score: 0.113
  7. Potential role of tissue microarrays for the study of biomarker expression in benign breast disease and normal breast tissue. Appl Immunohistochem Mol Morphol. 2009 Oct; 17(5):438-41.
    View in: PubMed
    Score: 0.109
  8. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res. 2008; 10(4):R67.
    View in: PubMed
    Score: 0.101
  9. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer. 2007 Jan 15; 109(2):180-7.
    View in: PubMed
    Score: 0.090
  10. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. Cancer. 2006 Sep 15; 107(6):1240-7.
    View in: PubMed
    Score: 0.088
  11. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study. Cancer. 2005 May 01; 103(9):1778-84.
    View in: PubMed
    Score: 0.080
  12. Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2020 11; 29(11):2358-2368.
    View in: PubMed
    Score: 0.058
  13. Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers. Br J Cancer. 2015 Sep 29; 113(7):1104-13.
    View in: PubMed
    Score: 0.041
  14. Intakes of fat and micronutrients between ages 13 and 18 years and the incidence of proliferative benign breast disease. Cancer Causes Control. 2015 Jan; 26(1):79-90.
    View in: PubMed
    Score: 0.039
  15. Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst. 2013 Oct 16; 105(20):1571-8.
    View in: PubMed
    Score: 0.036
  16. Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies. Breast Cancer Res Treat. 2013 May; 139(1):277-85.
    View in: PubMed
    Score: 0.035
  17. Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease. Breast Cancer Res Treat. 2012 Jul; 134(2):783-91.
    View in: PubMed
    Score: 0.033
  18. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011 Aug 03; 103(15):1179-89.
    View in: PubMed
    Score: 0.031
  19. Lifetime physical activity and the incidence of proliferative benign breast disease. Cancer Causes Control. 2011 Sep; 22(9):1297-305.
    View in: PubMed
    Score: 0.031
  20. COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. Breast Cancer Res Treat. 2011 Nov; 130(2):657-62.
    View in: PubMed
    Score: 0.031
  21. Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res. 2011 Apr 01; 17(7):1867-74.
    View in: PubMed
    Score: 0.030
  22. Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer. Breast Cancer Res Treat. 2011 Jul; 128(1):243-50.
    View in: PubMed
    Score: 0.030
  23. Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. Breast Cancer Res Treat. 2011 Feb; 126(1):185-92.
    View in: PubMed
    Score: 0.029
  24. Columnar cell lesions and subsequent breast cancer risk: a nested case-control study. Breast Cancer Res. 2010; 12(4):R61.
    View in: PubMed
    Score: 0.029
  25. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease. Int J Cancer. 2010 Jan 01; 126(1):180-90.
    View in: PubMed
    Score: 0.028
  26. Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies. Cancer. 2009 Apr 01; 115(7):1404-11.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.